Sara Nienow, Olena Leonchuk, Alan C O’Connor, Albert N Link
{"title":"Bringing technology to market: National Heart, Lung, and Blood Institute SBIR Phase IIB projects","authors":"Sara Nienow, Olena Leonchuk, Alan C O’Connor, Albert N Link","doi":"10.1093/scipol/scad063","DOIUrl":null,"url":null,"abstract":"Abstract The National Heart, Lung, and Blood Institute (NHLBI) is the fourth largest institute in the US National Institutes of Health (NIH). Surprisingly, there is a conspicuous void of policy studies related to the research activities of NHLBI in comparison to NIH or the National Cancer Institute. This paper investigates the likelihood that a business funded through NHLBI’s Small Business Innovation Research (SBIR) program will commercialize from its Phase IIB translational support. Commercialization is one performance metric that quantifies a policy dimension of the success of the funded SBIR project. Based on an empirical analysis of sixty-one Phase IIB projects, we find that the most significant covariate with the likelihood of commercialization is the growth in human capital within the business since the Phase IIB award.","PeriodicalId":47975,"journal":{"name":"Science and Public Policy","volume":"165 1","pages":"0"},"PeriodicalIF":2.6000,"publicationDate":"2023-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Science and Public Policy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/scipol/scad063","RegionNum":4,"RegionCategory":"管理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENVIRONMENTAL STUDIES","Score":null,"Total":0}
引用次数: 0
Abstract
Abstract The National Heart, Lung, and Blood Institute (NHLBI) is the fourth largest institute in the US National Institutes of Health (NIH). Surprisingly, there is a conspicuous void of policy studies related to the research activities of NHLBI in comparison to NIH or the National Cancer Institute. This paper investigates the likelihood that a business funded through NHLBI’s Small Business Innovation Research (SBIR) program will commercialize from its Phase IIB translational support. Commercialization is one performance metric that quantifies a policy dimension of the success of the funded SBIR project. Based on an empirical analysis of sixty-one Phase IIB projects, we find that the most significant covariate with the likelihood of commercialization is the growth in human capital within the business since the Phase IIB award.
期刊介绍：
Science and Public Policy is a leading refereed, international journal on public policies for science, technology and innovation, and on their implications for other public policies. It covers basic, applied, high, low, and any other types of S&T, and rich or poorer countries. It is read in around 70 countries, in universities (teaching and research), government ministries and agencies, consultancies, industry and elsewhere.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
